scispace - formally typeset
D

Dario Olivieri

Researcher at University of Parma

Publications -  163
Citations -  10464

Dario Olivieri is an academic researcher from University of Parma. The author has contributed to research in topics: COPD & Asthma. The author has an hindex of 40, co-authored 163 publications receiving 9889 citations. Previous affiliations of Dario Olivieri include Istituto Giannina Gaslini & University of Nebraska Medical Center.

Papers
More filters
Journal ArticleDOI

American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

TL;DR: The Diagnostic Process Is Dynamic Clinical Evaluation Radiological Evaluation Role of Surgical Lung Biopsy Unclassifiable Interstitial Pneumonia Bronchoalveolar Lavage Fluid Evaluation Idiopathic Pulmonary Fibrosis.
Journal ArticleDOI

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

TL;DR: N-acetylcysteine is ineffective at prevention of deterioration in lung function and prevention of exacerbations in patients with COPD and subgroup analysis suggested that the exacerbation rate might be reduced in patients not treated with inhaled corticosteroids.
Journal ArticleDOI

Airways Remodeling Is a Distinctive Feature of Asthma and Is Related to Severity of Disease

TL;DR: It is confirmed that airways remodeling is a very distinctive and characteristic pathologic finding of asthma and that it is related to the clinical and functional severity of asthma, but not to atopy or length of asthmatic history.
Journal ArticleDOI

Rescue Use of Beclomethasone and Albuterol in a Single Inhaler for Mild Asthma

TL;DR: In patients with mild asthma, the symptom-driven use of inhaled beclomethasone and albuterol in a single inhaler is as effective as regular use of asthma medication and is associated with a lower 6-month cumulative dose of the inhaled corticosteroid.
Journal ArticleDOI

Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: A placebo-controlled study

TL;DR: Results show that short-term treatment with low-dose FP reduces inflammatory cell infiltration into the lamina propria in bronchial biopsy specimens, and might control the intensity of airway remodeling in mild asthma.